Clinical Trial Update: Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected Patients [Phase 3]

View source ↗

Summary

Phase 3 trial assessed immunostimulation with maraviroc added to antiretroviral therapy in advanced HIV infection (AIDS) and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Maraviroc (maraviroc)

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV-1 Infection, AIDS | Phase 3 | Status: COMPLETED